PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97604519 |
Filing Date: 09/23/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97604519 |
---|---|
MARK INFORMATION | |
*MARK | SCAFFOLD |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | SCAFFOLD |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Integrated Nanotherapeutics Inc. |
INTERNAL ADDRESS | Suite 205 |
*MAILING ADDRESS | 4475 Wayburne Drive |
*CITY | Burnaby, BC |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Canada |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
V5G4X4 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation of British Columbia |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED | Canada |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Drug delivery agents in the form of lipid nanoparticles that facilitate the delivery of active pharmaceutical ingredients; pharmaceutical preparations for the treatment of diseases and disorders, namely, allergies, autoimmune diseases, cancer, cardiovascular diseases, genetic diseases, hematological diseases, infectious diseases, inflammatory diseases, metabolic diseases, neurological diseases, ocular diseases or respiratory diseases |
FILING BASIS | SECTION 1(b) |
FILING BASIS | SECTION 44(d) |
FOREIGN APPLICATION NUMBER | 2185468 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
Canada |
FOREIGN FILING DATE | 05/12/2022 |
INTENT TO PERFECT 44(d) |
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for registration, a valid claim of priority may be retained. |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Development of pharmaceutical preparations and medicines |
FILING BASIS | SECTION 1(b) |
FILING BASIS | SECTION 44(d) |
FOREIGN APPLICATION NUMBER | 2185468 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
Canada |
FOREIGN FILING DATE | 05/12/2022 |
INTENT TO PERFECT 44(d) |
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for registration, a valid claim of priority may be retained. |
ATTORNEY INFORMATION | |
NAME | Arlene D. Hanks |
ATTORNEY DOCKET NUMBER | 025172-044 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Moore & Van Allen PLLC |
INTERNAL ADDRESS | Suite 4700 |
STREET | 100 North Tryon Street |
CITY | Charlotte |
STATE | North Carolina |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 28202-4003 |
PHONE | 704-331-1000 |
FAX | 704-331-1159 |
EMAIL ADDRESS | ADH-PTOTMCorrespondence@mvalaw.com |
OTHER APPOINTED ATTORNEY | Ellen A. Andelman, Lauren E. Burrow, Kathryn G. Cole, Michele M. Glessner, Jeffrey R. Gray, Rebeca E. Harasimowicz, Chris Knors, Dickson M. Lupo, Samuel C. Merritt, Sara E. Miller, W. Kevin Ransom, Samantha N. Skains-Menchaca, John E. Slaughter, III, Peter B. Stewart, Henry B. Ward, III, F. Emmett Weindruch and J. Mark Wilson, all members of the bar of the State of North Carolina, and Tyler M. Seling, a member of the bar of the State of New York |
CORRESPONDENCE INFORMATION | |
NAME | Arlene D. Hanks |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | ADH-PTOTMCorrespondence@mvalaw.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | arlenehanks@mvalaw.com; iplaw@mvalaw.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 2 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 700 |
*TOTAL FEES PAID | 700 |
SIGNATURE INFORMATION | |
SIGNATURE | /arlenedhanks/ |
SIGNATORY'S NAME | Arlene D. Hanks |
SIGNATORY'S POSITION | Attorney of Record, North Carolina Bar Member |
SIGNATORY'S PHONE NUMBER | 919-286-8078 |
DATE SIGNED | 09/22/2022 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97604519 |
Filing Date: 09/23/2022 |
The applicant's current Correspondence Information: |
Arlene D. Hanks |
PRIMARY EMAIL FOR CORRESPONDENCE: ADH-PTOTMCorrespondence@mvalaw.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): arlenehanks@mvalaw.com; iplaw@mvalaw.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|